Two-dimensional hierarchical clustering was performed for the entire gene list (Table S1) incorporating expression data together with molecular and clinical characteristics (KRAS, BRAF, NRAS, TP53, PIK3CA, and PTEN mutations; microsatellite status, methylation subtype, tumor stage, tumor site, and recurrence data). Here, KRAS is linked to neoplasm.